PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; and genomics laboratory tests that provides genetic testing for reproductive health, pregnant women, couples who want to have a child, oncology tests, drug sensitivity, DNAandMe, and others. It also offers homecare health services for hemoglobin, ferritin, retilulosit, hematologi rutin, SARS-COV-2 omicron screening molecular test, and PCR SARS-COV-2 H+1 B2C; and SARS-CoV-2 screening services. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.
Metrics to compare | DGNS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDGNSPeersSector | |
---|---|---|---|---|
P/E Ratio | −74.8x | 9.5x | −0.5x | |
PEG Ratio | −1.61 | 0.00 | 0.00 | |
Price/Book | 1.0x | 1.3x | 2.6x | |
Price / LTM Sales | 1.2x | 2.2x | 3.3x | |
Upside (Analyst Target) | - | 20.3% | 45.1% | |
Fair Value Upside | Unlock | 8.0% | 7.4% | Unlock |